Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Meeting Bursaries

Bursaries for EACR Conferences

Researchers attend conferences to build their knowledge and share their findings, but obtaining funding to attend conferences can be very difficult, especially for early-career researchers. That's why we offer EACR Meeting Bursaries.

EACR Meeting Bursaries provide funds to help early-career EACR members to participate in our conferences.

Bursaries for the EACR Conference Series

Co-sponsored by Worldwide Cancer Research

What type of meeting? Small focused meetings of 100-250 participants, where the latest research topics and interaction for participants are the very highest priorities. 

What is provided? A free registration, and up to €500 to cover travel and accommodation

Visit our Conference Series page  and click on the conference you're interested in to learn more, including eligiblity requirements. 

Bursaries for Partnership Conferences

What type of meeting? We team up with other international cancer societies to organise conferences together.

What is provided? It depends on the meeting, but typically the bursary includes a free registration and funds towards travel and accommodation.


ESMO 2019 Congress in Partnership with the EACR: Translating science into better cancer patient care​

Bursaries for the EACR Congress

What type of meeting? Our Congress of 1500-2000 participants, covering all of the most up-to-date topics in plenary and parallel sessions, with 70+ top speakers.

What is provided? Usually up to €1300 to support registration, travel and accommodation. 

Look out for announcements about bursaries for EACR 2020, which will be held in Turin, Italy in 2020!


Arthur Dyer

Above: Arthur Dyer, meeting bursary recipient for the EACR conference 'Mechanisms to Therapies: Innovations in Cancer Metabolism' (Bilbao, Spain, 9-11 October 2018)

Purba Nag

Above: Purba Nag, meeting bursary recipient for the EACR conference 'Radiation Break-through: from DNA damage responses to precision cancer therapy' (Oxford, UK, 12-14 March 2018)

Share this page

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.